Intended strictly for professional research environments
well-tolerated in mice, rats, rabbits, and dogs with no serious organ toxicity.[34][35] Clinical Safety : Mild local irritation possible at injection sites, but no systemic adverse effects reported in trials.[36][37] Potential Risks : Theoretical concerns include pro-angiogenic effects potentially promoting tumor growth, though no evidence supports this in studies.[38] Long-term human data is limited, so monitoring is advised
The copper chelation gives extra enzymatic benefits not accessible with absolutely manufactured alternatives
But I also think that there are places, such as with experimental treatments like with BPC-157, we probably need to press pause on at least until theres some actual human trials that trend towards FDA approval and keep things where they are today
Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, Osullivan O